Greece is working towards precision medicine. Our focus is on making sure everyone is well-prepared to adopt pharmacogenomics (SPx) which determines with your genetic information how well your body absorbs and  metabolizes meds.

        First off, you gotta understand how the body reacts when drugs are consumed.

        Greece has been making strides in this field but still have a way to go.  This is especially true in places that have a smaller budget.

        But, don't get me wrong, Greece has shown it's committed to this, having studied the genetic markers in 18 European countries as the initial step. This alled them to see which drugs set off any  genetic flags.

        Greece has a solid start on PGx, but it's important to know where everyone stands.  As we all know everyones genetic make-up is different, so that means their PGx genetic markers can be different as well.

        Greece is pushing forward to make this a more integrated practice.

        The regulatory climate in Greece is different from the rest of Europe. It's important to know what's up with the Greek Medicines Agency and the European Medicines Agency.

        Greece has embarked on a journey to bring precision medicine into mainstream medical practices.  We know that the landscape is varied, especially between public and private labs.

        People with a good handle on PGx are key to this process.  Post secondary institutions are important to this work, as well as a labelling system that's patient centric.

            Education about PGx is vital. People need to know about PGx to figure out how well their body will respond to drugs.  Both public and private labs in Greece are offering PGx testing services.

            Academics are critical to this endeavour.  Ensuring that everyone is up to speed on what's going on in PGx.

        The regulatory climate in Greece is a bit complex.  Be aware of the differences between the Greek and European agencies.  Technology assessment should be considered as well.  Greece needs to make sure it's ready for this integration before venturing further.

            Private and public sectors have different approaches to the topic.  This is something to keep in mind while exploring this landscape.  There is an increasing demand for services in the private sector.

Unlocking Precision Medicine: Greece's Steps into Pharmacogenomics

Actions